nodes	percent_of_prediction	percent_of_DWPC	metapath
Exemestane—CYP3A4—type 2 diabetes mellitus	0.349	1	CbGaD
Exemestane—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.0564	0.152	CbGbCtD
Exemestane—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.0502	0.136	CbGbCtD
Exemestane—CYP3A4—Glipizide—type 2 diabetes mellitus	0.0459	0.124	CbGbCtD
Exemestane—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.0402	0.109	CbGbCtD
Exemestane—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.0363	0.0982	CbGbCtD
Exemestane—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.0275	0.0744	CbGbCtD
Exemestane—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.0264	0.0713	CbGbCtD
Exemestane—CYP3A4—Orlistat—type 2 diabetes mellitus	0.0264	0.0713	CbGbCtD
Exemestane—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.025	0.0675	CbGbCtD
Exemestane—CYP3A4—Glyburide—type 2 diabetes mellitus	0.0186	0.0503	CbGbCtD
Exemestane—CYP3A4—Losartan—type 2 diabetes mellitus	0.017	0.046	CbGbCtD
Exemestane—Prednisone—HSD11B1—type 2 diabetes mellitus	0.00144	0.25	CrCbGaD
Exemestane—Estropipate—SHBG—type 2 diabetes mellitus	0.000449	0.0783	CrCbGaD
Exemestane—Loteprednol—NR3C1—type 2 diabetes mellitus	0.000391	0.0682	CrCbGaD
Exemestane—Estrone—SHBG—type 2 diabetes mellitus	0.00028	0.0488	CrCbGaD
Exemestane—Methylprednisolone—NR3C1—type 2 diabetes mellitus	0.000243	0.0425	CrCbGaD
Exemestane—Testosterone—CYP11A1—type 2 diabetes mellitus	0.000241	0.0421	CrCbGaD
Exemestane—Estropipate—CYP1A2—type 2 diabetes mellitus	0.000234	0.0408	CrCbGaD
Exemestane—Conjugated Estrogens—ABCC2—type 2 diabetes mellitus	0.000219	0.0381	CrCbGaD
Exemestane—CYP3A4—Farnesoid X Receptor  Pathway—PPARGC1A—type 2 diabetes mellitus	0.000189	0.00538	CbGpPWpGaD
Exemestane—Prednisone—NR3C1—type 2 diabetes mellitus	0.000186	0.0325	CrCbGaD
Exemestane—CYP3A4—Estrogen metabolism—GSTM1—type 2 diabetes mellitus	0.000183	0.00521	CbGpPWpGaD
Exemestane—Prednisolone—NR3C1—type 2 diabetes mellitus	0.000172	0.0299	CrCbGaD
Exemestane—CYP19A1—Biological oxidations—MTR—type 2 diabetes mellitus	0.00017	0.00485	CbGpPWpGaD
Exemestane—Testosterone—SHBG—type 2 diabetes mellitus	0.00017	0.0296	CrCbGaD
Exemestane—CYP19A1—Biological oxidations—CYP11A1—type 2 diabetes mellitus	0.000165	0.00469	CbGpPWpGaD
Exemestane—CYP19A1—Metapathway biotransformation—CYP11A1—type 2 diabetes mellitus	0.000163	0.00463	CbGpPWpGaD
Exemestane—CYP19A1—Integrated Breast Cancer Pathway—HMGCR—type 2 diabetes mellitus	0.000161	0.00457	CbGpPWpGaD
Exemestane—Hyperhidrosis—Orlistat—type 2 diabetes mellitus	0.000155	0.000645	CcSEcCtD
Exemestane—Anorexia—Valsartan—type 2 diabetes mellitus	0.000155	0.000644	CcSEcCtD
Exemestane—Muscle spasms—Losartan—type 2 diabetes mellitus	0.000155	0.000644	CcSEcCtD
Exemestane—Estropipate—CYP3A4—type 2 diabetes mellitus	0.000155	0.027	CrCbGaD
Exemestane—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.000155	0.000643	CcSEcCtD
Exemestane—Chest pain—Metformin—type 2 diabetes mellitus	0.000154	0.000642	CcSEcCtD
Exemestane—Myalgia—Metformin—type 2 diabetes mellitus	0.000154	0.000642	CcSEcCtD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—PTGDS—type 2 diabetes mellitus	0.000154	0.00439	CbGpPWpGaD
Exemestane—Malaise—Irbesartan—type 2 diabetes mellitus	0.000154	0.000642	CcSEcCtD
Exemestane—Headache—Pioglitazone—type 2 diabetes mellitus	0.000154	0.000639	CcSEcCtD
Exemestane—Unspecified disorder of skin and subcutaneous tissue—Metformin—type 2 diabetes mellitus	0.000153	0.000637	CcSEcCtD
Exemestane—Leukopenia—Irbesartan—type 2 diabetes mellitus	0.000153	0.000637	CcSEcCtD
Exemestane—Estrone—CYP2E1—type 2 diabetes mellitus	0.000153	0.0267	CrCbGaD
Exemestane—Visual impairment—Ramipril—type 2 diabetes mellitus	0.000153	0.000636	CcSEcCtD
Exemestane—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	0.000153	0.000635	CcSEcCtD
Exemestane—Fatigue—Gliclazide—type 2 diabetes mellitus	0.000153	0.000634	CcSEcCtD
Exemestane—Nausea—Glipizide—type 2 diabetes mellitus	0.000152	0.000632	CcSEcCtD
Exemestane—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000152	0.000631	CcSEcCtD
Exemestane—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000152	0.000629	CcSEcCtD
Exemestane—Constipation—Gliclazide—type 2 diabetes mellitus	0.000151	0.000629	CcSEcCtD
Exemestane—Pain—Gliclazide—type 2 diabetes mellitus	0.000151	0.000629	CcSEcCtD
Exemestane—Rash—Glimepiride—type 2 diabetes mellitus	0.000151	0.000626	CcSEcCtD
Exemestane—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000151	0.000626	CcSEcCtD
Exemestane—Rash—Sitagliptin—type 2 diabetes mellitus	0.00015	0.000624	CcSEcCtD
Exemestane—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.00015	0.000624	CcSEcCtD
Exemestane—Erythema multiforme—Ramipril—type 2 diabetes mellitus	0.00015	0.000624	CcSEcCtD
Exemestane—Headache—Glimepiride—type 2 diabetes mellitus	0.00015	0.000622	CcSEcCtD
Exemestane—Cough—Irbesartan—type 2 diabetes mellitus	0.000149	0.000621	CcSEcCtD
Exemestane—Headache—Sitagliptin—type 2 diabetes mellitus	0.000149	0.00062	CcSEcCtD
Exemestane—Testosterone—AR—type 2 diabetes mellitus	0.000149	0.026	CrCbGaD
Exemestane—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	0.000148	0.000616	CcSEcCtD
Exemestane—Oedema—Metformin—type 2 diabetes mellitus	0.000148	0.000615	CcSEcCtD
Exemestane—Hypertension—Irbesartan—type 2 diabetes mellitus	0.000148	0.000614	CcSEcCtD
Exemestane—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000148	0.000613	CcSEcCtD
Exemestane—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—type 2 diabetes mellitus	0.000148	0.0042	CbGpPWpGaD
Exemestane—Infection—Metformin—type 2 diabetes mellitus	0.000147	0.000611	CcSEcCtD
Exemestane—Insomnia—Valsartan—type 2 diabetes mellitus	0.000147	0.000611	CcSEcCtD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—GPD2—type 2 diabetes mellitus	0.000146	0.00417	CbGpPWpGaD
Exemestane—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	0.000146	0.000608	CcSEcCtD
Exemestane—Paraesthesia—Valsartan—type 2 diabetes mellitus	0.000146	0.000607	CcSEcCtD
Exemestane—Conjugated Estrogens—CYP1A2—type 2 diabetes mellitus	0.000146	0.0255	CrCbGaD
Exemestane—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	0.000146	0.000606	CcSEcCtD
Exemestane—Arthralgia—Irbesartan—type 2 diabetes mellitus	0.000146	0.000606	CcSEcCtD
Exemestane—Chest pain—Irbesartan—type 2 diabetes mellitus	0.000146	0.000606	CcSEcCtD
Exemestane—Myalgia—Irbesartan—type 2 diabetes mellitus	0.000146	0.000606	CcSEcCtD
Exemestane—Estrone—CYP1A2—type 2 diabetes mellitus	0.000146	0.0254	CrCbGaD
Exemestane—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—type 2 diabetes mellitus	0.000145	0.00413	CbGpPWpGaD
Exemestane—Insomnia—Orlistat—type 2 diabetes mellitus	0.000145	0.000604	CcSEcCtD
Exemestane—Malaise—Losartan—type 2 diabetes mellitus	0.000145	0.000604	CcSEcCtD
Exemestane—Anxiety—Irbesartan—type 2 diabetes mellitus	0.000145	0.000604	CcSEcCtD
Exemestane—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.000145	0.000603	CcSEcCtD
Exemestane—Nervous system disorder—Metformin—type 2 diabetes mellitus	0.000145	0.000603	CcSEcCtD
Exemestane—Thrombocytopenia—Metformin—type 2 diabetes mellitus	0.000145	0.000602	CcSEcCtD
Exemestane—Dyspnoea—Valsartan—type 2 diabetes mellitus	0.000145	0.000602	CcSEcCtD
Exemestane—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	0.000145	0.000602	CcSEcCtD
Exemestane—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.000145	0.000601	CcSEcCtD
Exemestane—Paraesthesia—Orlistat—type 2 diabetes mellitus	0.000144	0.0006	CcSEcCtD
Exemestane—Leukopenia—Losartan—type 2 diabetes mellitus	0.000144	0.000599	CcSEcCtD
Exemestane—Skin disorder—Metformin—type 2 diabetes mellitus	0.000144	0.000598	CcSEcCtD
Exemestane—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—type 2 diabetes mellitus	0.000144	0.00409	CbGpPWpGaD
Exemestane—Immune system disorder—Ramipril—type 2 diabetes mellitus	0.000143	0.000596	CcSEcCtD
Exemestane—Hyperhidrosis—Metformin—type 2 diabetes mellitus	0.000143	0.000595	CcSEcCtD
Exemestane—Dyspepsia—Valsartan—type 2 diabetes mellitus	0.000143	0.000595	CcSEcCtD
Exemestane—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000143	0.000592	CcSEcCtD
Exemestane—Nausea—Glimepiride—type 2 diabetes mellitus	0.000142	0.00059	CcSEcCtD
Exemestane—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000142	0.000588	CcSEcCtD
Exemestane—Dyspepsia—Orlistat—type 2 diabetes mellitus	0.000141	0.000588	CcSEcCtD
Exemestane—Asthenia—Glyburide—type 2 diabetes mellitus	0.000141	0.000588	CcSEcCtD
Exemestane—Decreased appetite—Valsartan—type 2 diabetes mellitus	0.000141	0.000587	CcSEcCtD
Exemestane—Anorexia—Metformin—type 2 diabetes mellitus	0.000141	0.000587	CcSEcCtD
Exemestane—Methylprednisolone—CYP3A4—type 2 diabetes mellitus	0.000141	0.0246	CrCbGaD
Exemestane—Cough—Losartan—type 2 diabetes mellitus	0.000141	0.000584	CcSEcCtD
Exemestane—Urticaria—Gliclazide—type 2 diabetes mellitus	0.000141	0.000584	CcSEcCtD
Exemestane—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	0.00014	0.000583	CcSEcCtD
Exemestane—Alopecia—Ramipril—type 2 diabetes mellitus	0.00014	0.000583	CcSEcCtD
Exemestane—Fatigue—Valsartan—type 2 diabetes mellitus	0.00014	0.000583	CcSEcCtD
Exemestane—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.00014	0.000581	CcSEcCtD
Exemestane—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.00014	0.000581	CcSEcCtD
Exemestane—Oedema—Irbesartan—type 2 diabetes mellitus	0.00014	0.000581	CcSEcCtD
Exemestane—Decreased appetite—Orlistat—type 2 diabetes mellitus	0.00014	0.00058	CcSEcCtD
Exemestane—Pruritus—Glyburide—type 2 diabetes mellitus	0.000139	0.000579	CcSEcCtD
Exemestane—Mental disorder—Ramipril—type 2 diabetes mellitus	0.000139	0.000578	CcSEcCtD
Exemestane—Constipation—Valsartan—type 2 diabetes mellitus	0.000139	0.000578	CcSEcCtD
Exemestane—Infection—Irbesartan—type 2 diabetes mellitus	0.000139	0.000577	CcSEcCtD
Exemestane—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	0.000139	0.000576	CcSEcCtD
Exemestane—Fatigue—Orlistat—type 2 diabetes mellitus	0.000139	0.000576	CcSEcCtD
Exemestane—Pain—Orlistat—type 2 diabetes mellitus	0.000137	0.000571	CcSEcCtD
Exemestane—Chest pain—Losartan—type 2 diabetes mellitus	0.000137	0.00057	CcSEcCtD
Exemestane—Arthralgia—Losartan—type 2 diabetes mellitus	0.000137	0.00057	CcSEcCtD
Exemestane—Myalgia—Losartan—type 2 diabetes mellitus	0.000137	0.00057	CcSEcCtD
Exemestane—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000137	0.00057	CcSEcCtD
Exemestane—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	0.000137	0.000569	CcSEcCtD
Exemestane—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	0.000137	0.000569	CcSEcCtD
Exemestane—Anxiety—Losartan—type 2 diabetes mellitus	0.000137	0.000568	CcSEcCtD
Exemestane—CYP19A1—Biological oxidations—CYP2E1—type 2 diabetes mellitus	0.000136	0.00387	CbGpPWpGaD
Exemestane—Rash—Bromocriptine—type 2 diabetes mellitus	0.000136	0.000565	CcSEcCtD
Exemestane—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000136	0.000564	CcSEcCtD
Exemestane—Skin disorder—Irbesartan—type 2 diabetes mellitus	0.000136	0.000564	CcSEcCtD
Exemestane—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	0.000135	0.000561	CcSEcCtD
Exemestane—Headache—Bromocriptine—type 2 diabetes mellitus	0.000135	0.000561	CcSEcCtD
Exemestane—Estropipate—ALB—type 2 diabetes mellitus	0.000135	0.0236	CrCbGaD
Exemestane—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	0.000135	0.000561	CcSEcCtD
Exemestane—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000135	0.00056	CcSEcCtD
Exemestane—CYP19A1—Biological oxidations—CYP1A2—type 2 diabetes mellitus	0.000135	0.00383	CbGpPWpGaD
Exemestane—CYP19A1—Metapathway biotransformation—CYP2E1—type 2 diabetes mellitus	0.000134	0.00382	CbGpPWpGaD
Exemestane—Anorexia—Irbesartan—type 2 diabetes mellitus	0.000133	0.000554	CcSEcCtD
Exemestane—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	0.000133	0.000553	CcSEcCtD
Exemestane—Paraesthesia—Metformin—type 2 diabetes mellitus	0.000133	0.000553	CcSEcCtD
Exemestane—Muscle spasms—Ramipril—type 2 diabetes mellitus	0.000133	0.000552	CcSEcCtD
Exemestane—CYP19A1—Metapathway biotransformation—CYP1A2—type 2 diabetes mellitus	0.000133	0.00378	CbGpPWpGaD
Exemestane—Confusional state—Losartan—type 2 diabetes mellitus	0.000133	0.000551	CcSEcCtD
Exemestane—Feeling abnormal—Orlistat—type 2 diabetes mellitus	0.000132	0.00055	CcSEcCtD
Exemestane—Dyspnoea—Metformin—type 2 diabetes mellitus	0.000132	0.000549	CcSEcCtD
Exemestane—Oedema—Losartan—type 2 diabetes mellitus	0.000132	0.000546	CcSEcCtD
Exemestane—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	0.000131	0.000546	CcSEcCtD
Exemestane—CYP19A1—Biological oxidations—CYP3A4—type 2 diabetes mellitus	0.000131	0.00374	CbGpPWpGaD
Exemestane—CYP19A1—Integrated Breast Cancer Pathway—AR—type 2 diabetes mellitus	0.000131	0.00373	CbGpPWpGaD
Exemestane—Infection—Losartan—type 2 diabetes mellitus	0.000131	0.000543	CcSEcCtD
Exemestane—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.00013	0.000542	CcSEcCtD
Exemestane—Dyspepsia—Metformin—type 2 diabetes mellitus	0.00013	0.000542	CcSEcCtD
Exemestane—CYP19A1—Metapathway biotransformation—CYP3A4—type 2 diabetes mellitus	0.00013	0.00368	CbGpPWpGaD
Exemestane—Urticaria—Valsartan—type 2 diabetes mellitus	0.000129	0.000537	CcSEcCtD
Exemestane—Nervous system disorder—Losartan—type 2 diabetes mellitus	0.000129	0.000536	CcSEcCtD
Exemestane—Thrombocytopenia—Losartan—type 2 diabetes mellitus	0.000129	0.000535	CcSEcCtD
Exemestane—Decreased appetite—Metformin—type 2 diabetes mellitus	0.000129	0.000535	CcSEcCtD
Exemestane—CYP19A1—FSH signaling pathway—AKT1—type 2 diabetes mellitus	0.000129	0.00366	CbGpPWpGaD
Exemestane—Abdominal pain—Valsartan—type 2 diabetes mellitus	0.000129	0.000534	CcSEcCtD
Exemestane—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000128	0.000532	CcSEcCtD
Exemestane—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	0.000128	0.000531	CcSEcCtD
Exemestane—Fatigue—Metformin—type 2 diabetes mellitus	0.000128	0.000531	CcSEcCtD
Exemestane—Urticaria—Orlistat—type 2 diabetes mellitus	0.000128	0.00053	CcSEcCtD
Exemestane—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	0.000127	0.000529	CcSEcCtD
Exemestane—Hyperhidrosis—Losartan—type 2 diabetes mellitus	0.000127	0.000528	CcSEcCtD
Exemestane—Abdominal pain—Orlistat—type 2 diabetes mellitus	0.000127	0.000528	CcSEcCtD
Exemestane—Body temperature increased—Orlistat—type 2 diabetes mellitus	0.000127	0.000528	CcSEcCtD
Exemestane—Asthenia—Gliclazide—type 2 diabetes mellitus	0.000127	0.000528	CcSEcCtD
Exemestane—Constipation—Metformin—type 2 diabetes mellitus	0.000127	0.000526	CcSEcCtD
Exemestane—Paraesthesia—Irbesartan—type 2 diabetes mellitus	0.000126	0.000521	CcSEcCtD
Exemestane—Anorexia—Losartan—type 2 diabetes mellitus	0.000125	0.000521	CcSEcCtD
Exemestane—Vomiting—Glyburide—type 2 diabetes mellitus	0.000125	0.000521	CcSEcCtD
Exemestane—Pruritus—Gliclazide—type 2 diabetes mellitus	0.000125	0.00052	CcSEcCtD
Exemestane—CYP3A4—Constitutive Androstane Receptor Pathway—PPARGC1A—type 2 diabetes mellitus	0.000125	0.00355	CbGpPWpGaD
Exemestane—CYP19A1—Integrated Breast Cancer Pathway—TGFBR2—type 2 diabetes mellitus	0.000125	0.00355	CbGpPWpGaD
Exemestane—Malaise—Ramipril—type 2 diabetes mellitus	0.000125	0.000518	CcSEcCtD
Exemestane—Dyspnoea—Irbesartan—type 2 diabetes mellitus	0.000125	0.000518	CcSEcCtD
Exemestane—Rash—Glyburide—type 2 diabetes mellitus	0.000124	0.000516	CcSEcCtD
Exemestane—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000124	0.000516	CcSEcCtD
Exemestane—Leukopenia—Ramipril—type 2 diabetes mellitus	0.000124	0.000514	CcSEcCtD
Exemestane—Headache—Glyburide—type 2 diabetes mellitus	0.000123	0.000513	CcSEcCtD
Exemestane—Dyspepsia—Irbesartan—type 2 diabetes mellitus	0.000123	0.000511	CcSEcCtD
Exemestane—Feeling abnormal—Metformin—type 2 diabetes mellitus	0.000122	0.000507	CcSEcCtD
Exemestane—Decreased appetite—Irbesartan—type 2 diabetes mellitus	0.000121	0.000505	CcSEcCtD
Exemestane—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.000121	0.000503	CcSEcCtD
Exemestane—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	0.000121	0.000503	CcSEcCtD
Exemestane—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	0.000121	0.000501	CcSEcCtD
Exemestane—Cough—Ramipril—type 2 diabetes mellitus	0.000121	0.000501	CcSEcCtD
Exemestane—Fatigue—Irbesartan—type 2 diabetes mellitus	0.00012	0.000501	CcSEcCtD
Exemestane—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	0.00012	0.000498	CcSEcCtD
Exemestane—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.00012	0.000498	CcSEcCtD
Exemestane—Pain—Irbesartan—type 2 diabetes mellitus	0.00012	0.000497	CcSEcCtD
Exemestane—Constipation—Irbesartan—type 2 diabetes mellitus	0.00012	0.000497	CcSEcCtD
Exemestane—CYP19A1—Integrated Breast Cancer Pathway—SIRT1—type 2 diabetes mellitus	0.000119	0.0034	CbGpPWpGaD
Exemestane—Insomnia—Losartan—type 2 diabetes mellitus	0.000119	0.000494	CcSEcCtD
Exemestane—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.000118	0.000492	CcSEcCtD
Exemestane—Paraesthesia—Losartan—type 2 diabetes mellitus	0.000118	0.000491	CcSEcCtD
Exemestane—Urticaria—Metformin—type 2 diabetes mellitus	0.000118	0.000489	CcSEcCtD
Exemestane—Myalgia—Ramipril—type 2 diabetes mellitus	0.000118	0.000489	CcSEcCtD
Exemestane—Arthralgia—Ramipril—type 2 diabetes mellitus	0.000118	0.000489	CcSEcCtD
Exemestane—Chest pain—Ramipril—type 2 diabetes mellitus	0.000118	0.000489	CcSEcCtD
Exemestane—Dyspnoea—Losartan—type 2 diabetes mellitus	0.000117	0.000487	CcSEcCtD
Exemestane—Anxiety—Ramipril—type 2 diabetes mellitus	0.000117	0.000487	CcSEcCtD
Exemestane—Nausea—Glyburide—type 2 diabetes mellitus	0.000117	0.000487	CcSEcCtD
Exemestane—Abdominal pain—Metformin—type 2 diabetes mellitus	0.000117	0.000486	CcSEcCtD
Exemestane—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000117	0.000486	CcSEcCtD
Exemestane—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	0.000117	0.000485	CcSEcCtD
Exemestane—Asthenia—Valsartan—type 2 diabetes mellitus	0.000117	0.000485	CcSEcCtD
Exemestane—Dyspepsia—Losartan—type 2 diabetes mellitus	0.000116	0.000481	CcSEcCtD
Exemestane—Asthenia—Orlistat—type 2 diabetes mellitus	0.000115	0.000479	CcSEcCtD
Exemestane—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	0.000115	0.000479	CcSEcCtD
Exemestane—Pruritus—Valsartan—type 2 diabetes mellitus	0.000115	0.000478	CcSEcCtD
Exemestane—Decreased appetite—Losartan—type 2 diabetes mellitus	0.000114	0.000475	CcSEcCtD
Exemestane—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	0.000114	0.000475	CcSEcCtD
Exemestane—CYP3A4—Tryptophan metabolism—CYP2E1—type 2 diabetes mellitus	0.000114	0.00325	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—OXCT1—type 2 diabetes mellitus	0.000114	0.00324	CbGpPWpGaD
Exemestane—Confusional state—Ramipril—type 2 diabetes mellitus	0.000114	0.000472	CcSEcCtD
Exemestane—Pruritus—Orlistat—type 2 diabetes mellitus	0.000114	0.000472	CcSEcCtD
Exemestane—Fatigue—Losartan—type 2 diabetes mellitus	0.000113	0.000471	CcSEcCtD
Exemestane—CYP3A4—Tryptophan metabolism—CYP1A2—type 2 diabetes mellitus	0.000113	0.00321	CbGpPWpGaD
Exemestane—Oedema—Ramipril—type 2 diabetes mellitus	0.000113	0.000469	CcSEcCtD
Exemestane—Vomiting—Gliclazide—type 2 diabetes mellitus	0.000113	0.000468	CcSEcCtD
Exemestane—Constipation—Losartan—type 2 diabetes mellitus	0.000112	0.000467	CcSEcCtD
Exemestane—Pain—Losartan—type 2 diabetes mellitus	0.000112	0.000467	CcSEcCtD
Exemestane—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP11A1—type 2 diabetes mellitus	0.000112	0.00318	CbGpPWpGaD
Exemestane—Rash—Gliclazide—type 2 diabetes mellitus	0.000112	0.000464	CcSEcCtD
Exemestane—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.000112	0.000463	CcSEcCtD
Exemestane—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.000111	0.000462	CcSEcCtD
Exemestane—Urticaria—Irbesartan—type 2 diabetes mellitus	0.000111	0.000461	CcSEcCtD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—SRD5A1—type 2 diabetes mellitus	0.000111	0.00316	CbGpPWpGaD
Exemestane—Headache—Gliclazide—type 2 diabetes mellitus	0.000111	0.000461	CcSEcCtD
Exemestane—Nervous system disorder—Ramipril—type 2 diabetes mellitus	0.000111	0.00046	CcSEcCtD
Exemestane—Body temperature increased—Irbesartan—type 2 diabetes mellitus	0.00011	0.000459	CcSEcCtD
Exemestane—Abdominal pain—Irbesartan—type 2 diabetes mellitus	0.00011	0.000459	CcSEcCtD
Exemestane—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	0.00011	0.000459	CcSEcCtD
Exemestane—CYP3A4—Oxidation by Cytochrome P450—CYP11A1—type 2 diabetes mellitus	0.00011	0.00314	CbGpPWpGaD
Exemestane—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.00011	0.000457	CcSEcCtD
Exemestane—Skin disorder—Ramipril—type 2 diabetes mellitus	0.00011	0.000455	CcSEcCtD
Exemestane—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	0.000109	0.000453	CcSEcCtD
Exemestane—Feeling abnormal—Losartan—type 2 diabetes mellitus	0.000108	0.00045	CcSEcCtD
Exemestane—Prednisone—CYP3A4—type 2 diabetes mellitus	0.000108	0.0188	CrCbGaD
Exemestane—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	0.000108	0.000447	CcSEcCtD
Exemestane—Dizziness—Valsartan—type 2 diabetes mellitus	0.000108	0.000447	CcSEcCtD
Exemestane—Anorexia—Ramipril—type 2 diabetes mellitus	0.000108	0.000447	CcSEcCtD
Exemestane—Dizziness—Orlistat—type 2 diabetes mellitus	0.000106	0.000442	CcSEcCtD
Exemestane—Asthenia—Metformin—type 2 diabetes mellitus	0.000106	0.000441	CcSEcCtD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—STAR—type 2 diabetes mellitus	0.000106	0.00301	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—ACACA—type 2 diabetes mellitus	0.000106	0.00301	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—HSD17B3—type 2 diabetes mellitus	0.000106	0.00301	CbGpPWpGaD
Exemestane—Nausea—Gliclazide—type 2 diabetes mellitus	0.000105	0.000437	CcSEcCtD
Exemestane—Pruritus—Metformin—type 2 diabetes mellitus	0.000105	0.000435	CcSEcCtD
Exemestane—Urticaria—Losartan—type 2 diabetes mellitus	0.000104	0.000434	CcSEcCtD
Exemestane—Abdominal pain—Losartan—type 2 diabetes mellitus	0.000104	0.000432	CcSEcCtD
Exemestane—Body temperature increased—Losartan—type 2 diabetes mellitus	0.000104	0.000432	CcSEcCtD
Exemestane—Vomiting—Valsartan—type 2 diabetes mellitus	0.000103	0.00043	CcSEcCtD
Exemestane—CYP19A1—Biological oxidations—GSTM1—type 2 diabetes mellitus	0.000103	0.00294	CbGpPWpGaD
Exemestane—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	0.000103	0.000428	CcSEcCtD
Exemestane—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	0.000103	0.000427	CcSEcCtD
Exemestane—Rash—Valsartan—type 2 diabetes mellitus	0.000103	0.000426	CcSEcCtD
Exemestane—Dermatitis—Valsartan—type 2 diabetes mellitus	0.000102	0.000426	CcSEcCtD
Exemestane—Vomiting—Orlistat—type 2 diabetes mellitus	0.000102	0.000425	CcSEcCtD
Exemestane—Insomnia—Ramipril—type 2 diabetes mellitus	0.000102	0.000424	CcSEcCtD
Exemestane—Headache—Valsartan—type 2 diabetes mellitus	0.000102	0.000423	CcSEcCtD
Exemestane—CYP19A1—Metapathway biotransformation—GSTM1—type 2 diabetes mellitus	0.000102	0.0029	CbGpPWpGaD
Exemestane—Diarrhoea—Metformin—type 2 diabetes mellitus	0.000101	0.000421	CcSEcCtD
Exemestane—Rash—Orlistat—type 2 diabetes mellitus	0.000101	0.000421	CcSEcCtD
Exemestane—Paraesthesia—Ramipril—type 2 diabetes mellitus	0.000101	0.000421	CcSEcCtD
Exemestane—Dermatitis—Orlistat—type 2 diabetes mellitus	0.000101	0.000421	CcSEcCtD
Exemestane—Headache—Orlistat—type 2 diabetes mellitus	0.000101	0.000418	CcSEcCtD
Exemestane—Dyspnoea—Ramipril—type 2 diabetes mellitus	0.000101	0.000418	CcSEcCtD
Exemestane—Asthenia—Irbesartan—type 2 diabetes mellitus	0.0001	0.000417	CcSEcCtD
Exemestane—Prednisolone—CYP3A4—type 2 diabetes mellitus	9.95e-05	0.0173	CrCbGaD
Exemestane—Dyspepsia—Ramipril—type 2 diabetes mellitus	9.93e-05	0.000412	CcSEcCtD
Exemestane—Pruritus—Irbesartan—type 2 diabetes mellitus	9.89e-05	0.000411	CcSEcCtD
Exemestane—Decreased appetite—Ramipril—type 2 diabetes mellitus	9.8e-05	0.000407	CcSEcCtD
Exemestane—CYP3A4—Biological oxidations—MAT1A—type 2 diabetes mellitus	9.8e-05	0.00279	CbGpPWpGaD
Exemestane—Dizziness—Metformin—type 2 diabetes mellitus	9.79e-05	0.000407	CcSEcCtD
Exemestane—CYP19A1—Integrated Breast Cancer Pathway—MMP1—type 2 diabetes mellitus	9.74e-05	0.00277	CbGpPWpGaD
Exemestane—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	9.74e-05	0.000405	CcSEcCtD
Exemestane—Fatigue—Ramipril—type 2 diabetes mellitus	9.72e-05	0.000404	CcSEcCtD
Exemestane—Hypersensitivity—Losartan—type 2 diabetes mellitus	9.69e-05	0.000403	CcSEcCtD
Exemestane—Conjugated Estrogens—CYP3A4—type 2 diabetes mellitus	9.66e-05	0.0169	CrCbGaD
Exemestane—Nausea—Valsartan—type 2 diabetes mellitus	9.66e-05	0.000401	CcSEcCtD
Exemestane—Constipation—Ramipril—type 2 diabetes mellitus	9.64e-05	0.000401	CcSEcCtD
Exemestane—Estrone—CYP3A4—type 2 diabetes mellitus	9.64e-05	0.0168	CrCbGaD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—NCOA6—type 2 diabetes mellitus	9.6e-05	0.00273	CbGpPWpGaD
Exemestane—Diarrhoea—Irbesartan—type 2 diabetes mellitus	9.56e-05	0.000397	CcSEcCtD
Exemestane—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—type 2 diabetes mellitus	9.55e-05	0.00272	CbGpPWpGaD
Exemestane—Nausea—Orlistat—type 2 diabetes mellitus	9.55e-05	0.000397	CcSEcCtD
Exemestane—Asthenia—Losartan—type 2 diabetes mellitus	9.44e-05	0.000392	CcSEcCtD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—HSD11B1—type 2 diabetes mellitus	9.44e-05	0.00268	CbGpPWpGaD
Exemestane—Vomiting—Metformin—type 2 diabetes mellitus	9.42e-05	0.000391	CcSEcCtD
Exemestane—Prednisone—ALB—type 2 diabetes mellitus	9.41e-05	0.0164	CrCbGaD
Exemestane—Rash—Metformin—type 2 diabetes mellitus	9.34e-05	0.000388	CcSEcCtD
Exemestane—Dermatitis—Metformin—type 2 diabetes mellitus	9.33e-05	0.000388	CcSEcCtD
Exemestane—Pruritus—Losartan—type 2 diabetes mellitus	9.31e-05	0.000387	CcSEcCtD
Exemestane—Feeling abnormal—Ramipril—type 2 diabetes mellitus	9.29e-05	0.000386	CcSEcCtD
Exemestane—Headache—Metformin—type 2 diabetes mellitus	9.28e-05	0.000385	CcSEcCtD
Exemestane—Dizziness—Irbesartan—type 2 diabetes mellitus	9.24e-05	0.000384	CcSEcCtD
Exemestane—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—type 2 diabetes mellitus	9.23e-05	0.00263	CbGpPWpGaD
Exemestane—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	9.22e-05	0.000383	CcSEcCtD
Exemestane—CYP3A4—Tryptophan metabolism—CAT—type 2 diabetes mellitus	9.16e-05	0.00261	CbGpPWpGaD
Exemestane—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—type 2 diabetes mellitus	9.12e-05	0.0026	CbGpPWpGaD
Exemestane—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—type 2 diabetes mellitus	9.11e-05	0.00259	CbGpPWpGaD
Exemestane—CYP3A4—Phase 1 - Functionalization of compounds—CYP11A1—type 2 diabetes mellitus	9.06e-05	0.00258	CbGpPWpGaD
Exemestane—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—type 2 diabetes mellitus	9e-05	0.00256	CbGpPWpGaD
Exemestane—Diarrhoea—Losartan—type 2 diabetes mellitus	9e-05	0.000374	CcSEcCtD
Exemestane—Urticaria—Ramipril—type 2 diabetes mellitus	8.96e-05	0.000372	CcSEcCtD
Exemestane—Body temperature increased—Ramipril—type 2 diabetes mellitus	8.92e-05	0.00037	CcSEcCtD
Exemestane—Abdominal pain—Ramipril—type 2 diabetes mellitus	8.92e-05	0.00037	CcSEcCtD
Exemestane—Vomiting—Irbesartan—type 2 diabetes mellitus	8.89e-05	0.000369	CcSEcCtD
Exemestane—Rash—Irbesartan—type 2 diabetes mellitus	8.81e-05	0.000366	CcSEcCtD
Exemestane—Dermatitis—Irbesartan—type 2 diabetes mellitus	8.8e-05	0.000366	CcSEcCtD
Exemestane—Nausea—Metformin—type 2 diabetes mellitus	8.8e-05	0.000366	CcSEcCtD
Exemestane—Headache—Irbesartan—type 2 diabetes mellitus	8.76e-05	0.000364	CcSEcCtD
Exemestane—Dizziness—Losartan—type 2 diabetes mellitus	8.7e-05	0.000361	CcSEcCtD
Exemestane—Estrone—ALB—type 2 diabetes mellitus	8.41e-05	0.0147	CrCbGaD
Exemestane—CYP19A1—Integrated Breast Cancer Pathway—IRS1—type 2 diabetes mellitus	8.41e-05	0.00239	CbGpPWpGaD
Exemestane—Vomiting—Losartan—type 2 diabetes mellitus	8.36e-05	0.000347	CcSEcCtD
Exemestane—Hypersensitivity—Ramipril—type 2 diabetes mellitus	8.31e-05	0.000345	CcSEcCtD
Exemestane—Nausea—Irbesartan—type 2 diabetes mellitus	8.3e-05	0.000345	CcSEcCtD
Exemestane—Rash—Losartan—type 2 diabetes mellitus	8.29e-05	0.000345	CcSEcCtD
Exemestane—Dermatitis—Losartan—type 2 diabetes mellitus	8.29e-05	0.000344	CcSEcCtD
Exemestane—Headache—Losartan—type 2 diabetes mellitus	8.24e-05	0.000342	CcSEcCtD
Exemestane—Asthenia—Ramipril—type 2 diabetes mellitus	8.09e-05	0.000336	CcSEcCtD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—LPA—type 2 diabetes mellitus	8.02e-05	0.00228	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—HSD3B2—type 2 diabetes mellitus	8.02e-05	0.00228	CbGpPWpGaD
Exemestane—Pruritus—Ramipril—type 2 diabetes mellitus	7.98e-05	0.000332	CcSEcCtD
Exemestane—CYP19A1—Integrated Breast Cancer Pathway—CASP8—type 2 diabetes mellitus	7.92e-05	0.00225	CbGpPWpGaD
Exemestane—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—type 2 diabetes mellitus	7.89e-05	0.00225	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—BHMT—type 2 diabetes mellitus	7.87e-05	0.00224	CbGpPWpGaD
Exemestane—Nausea—Losartan—type 2 diabetes mellitus	7.81e-05	0.000325	CcSEcCtD
Exemestane—Diarrhoea—Ramipril—type 2 diabetes mellitus	7.72e-05	0.000321	CcSEcCtD
Exemestane—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—type 2 diabetes mellitus	7.48e-05	0.00213	CbGpPWpGaD
Exemestane—Dizziness—Ramipril—type 2 diabetes mellitus	7.46e-05	0.00031	CcSEcCtD
Exemestane—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—type 2 diabetes mellitus	7.4e-05	0.0021	CbGpPWpGaD
Exemestane—Vomiting—Ramipril—type 2 diabetes mellitus	7.17e-05	0.000298	CcSEcCtD
Exemestane—Rash—Ramipril—type 2 diabetes mellitus	7.11e-05	0.000295	CcSEcCtD
Exemestane—Dermatitis—Ramipril—type 2 diabetes mellitus	7.1e-05	0.000295	CcSEcCtD
Exemestane—Headache—Ramipril—type 2 diabetes mellitus	7.07e-05	0.000294	CcSEcCtD
Exemestane—CYP19A1—Metabolism—AANAT—type 2 diabetes mellitus	6.88e-05	0.00196	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—PTGDS—type 2 diabetes mellitus	6.88e-05	0.00196	CbGpPWpGaD
Exemestane—CYP19A1—Integrated Breast Cancer Pathway—BCL2—type 2 diabetes mellitus	6.8e-05	0.00193	CbGpPWpGaD
Exemestane—Nausea—Ramipril—type 2 diabetes mellitus	6.7e-05	0.000278	CcSEcCtD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—CPT1A—type 2 diabetes mellitus	6.54e-05	0.00186	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—CDO1—type 2 diabetes mellitus	6.52e-05	0.00186	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—GPD2—type 2 diabetes mellitus	6.52e-05	0.00186	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—LIPC—type 2 diabetes mellitus	6.37e-05	0.00181	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—CYP11A1—type 2 diabetes mellitus	6.33e-05	0.0018	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—AK1—type 2 diabetes mellitus	6.22e-05	0.00177	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—CETP—type 2 diabetes mellitus	6.15e-05	0.00175	CbGpPWpGaD
Exemestane—CYP19A1—Integrated Breast Cancer Pathway—CASP3—type 2 diabetes mellitus	5.99e-05	0.0017	CbGpPWpGaD
Exemestane—Testosterone—CYP3A4—type 2 diabetes mellitus	5.86e-05	0.0102	CrCbGaD
Exemestane—CYP19A1—Metabolism—MAT1A—type 2 diabetes mellitus	5.74e-05	0.00163	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—SLC5A4—type 2 diabetes mellitus	5.74e-05	0.00163	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—SREBF1—type 2 diabetes mellitus	5.72e-05	0.00163	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—CTGF—type 2 diabetes mellitus	5.61e-05	0.0016	CbGpPWpGaD
Exemestane—CYP19A1—Integrated Breast Cancer Pathway—NFKB1—type 2 diabetes mellitus	5.6e-05	0.00159	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—HMGCR—type 2 diabetes mellitus	5.56e-05	0.00158	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—ENPP1—type 2 diabetes mellitus	5.55e-05	0.00158	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—HBA2—type 2 diabetes mellitus	5.55e-05	0.00158	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—G6PC—type 2 diabetes mellitus	5.55e-05	0.00158	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—ND1—type 2 diabetes mellitus	5.55e-05	0.00158	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—PPP1R3C—type 2 diabetes mellitus	5.55e-05	0.00158	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—GCGR—type 2 diabetes mellitus	5.37e-05	0.00153	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—CYP1A2—type 2 diabetes mellitus	5.17e-05	0.00147	CbGpPWpGaD
Exemestane—Testosterone—ALB—type 2 diabetes mellitus	5.11e-05	0.00891	CrCbGaD
Exemestane—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—type 2 diabetes mellitus	5.09e-05	0.00145	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—OXCT1—type 2 diabetes mellitus	5.07e-05	0.00144	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—CYTB—type 2 diabetes mellitus	5.07e-05	0.00144	CbGpPWpGaD
Exemestane—CYP3A4—Biological oxidations—MTR—type 2 diabetes mellitus	4.97e-05	0.00141	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—SRD5A1—type 2 diabetes mellitus	4.94e-05	0.00141	CbGpPWpGaD
Exemestane—CYP3A4—Biological oxidations—CYP11A1—type 2 diabetes mellitus	4.81e-05	0.00137	CbGpPWpGaD
Exemestane—CYP3A4—Metapathway biotransformation—CYP11A1—type 2 diabetes mellitus	4.75e-05	0.00135	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—STAR—type 2 diabetes mellitus	4.72e-05	0.00134	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—ACACA—type 2 diabetes mellitus	4.72e-05	0.00134	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—HSD17B3—type 2 diabetes mellitus	4.72e-05	0.00134	CbGpPWpGaD
Exemestane—CYP19A1—Integrated Breast Cancer Pathway—EGFR—type 2 diabetes mellitus	4.58e-05	0.0013	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—ABCC8—type 2 diabetes mellitus	4.52e-05	0.00129	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—CBS—type 2 diabetes mellitus	4.52e-05	0.00129	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—COX2—type 2 diabetes mellitus	4.35e-05	0.00124	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—SLC5A2—type 2 diabetes mellitus	4.35e-05	0.00124	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—NCOA6—type 2 diabetes mellitus	4.27e-05	0.00122	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—PPARGC1A—type 2 diabetes mellitus	4.27e-05	0.00122	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—HSD11B1—type 2 diabetes mellitus	4.2e-05	0.0012	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—UCP3—type 2 diabetes mellitus	4.2e-05	0.0012	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—UCP2—type 2 diabetes mellitus	4.2e-05	0.0012	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—APOB—type 2 diabetes mellitus	4.07e-05	0.00116	CbGpPWpGaD
Exemestane—CYP3A4—Biological oxidations—CYP2E1—type 2 diabetes mellitus	3.97e-05	0.00113	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—PCK1—type 2 diabetes mellitus	3.95e-05	0.00112	CbGpPWpGaD
Exemestane—CYP3A4—Biological oxidations—CYP1A2—type 2 diabetes mellitus	3.93e-05	0.00112	CbGpPWpGaD
Exemestane—CYP3A4—Metapathway biotransformation—CYP2E1—type 2 diabetes mellitus	3.92e-05	0.00111	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—LPL—type 2 diabetes mellitus	3.89e-05	0.00111	CbGpPWpGaD
Exemestane—CYP3A4—Metapathway biotransformation—CYP1A2—type 2 diabetes mellitus	3.88e-05	0.0011	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—GPX1—type 2 diabetes mellitus	3.79e-05	0.00108	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—HK1—type 2 diabetes mellitus	3.7e-05	0.00105	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	3.7e-05	0.00105	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—KCNJ11—type 2 diabetes mellitus	3.57e-05	0.00102	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—GCKR—type 2 diabetes mellitus	3.57e-05	0.00102	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—LPA—type 2 diabetes mellitus	3.57e-05	0.00102	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—HSD3B2—type 2 diabetes mellitus	3.57e-05	0.00102	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	3.44e-05	0.000977	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—ALDOB—type 2 diabetes mellitus	3.43e-05	0.000975	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	3.33e-05	0.000947	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	3.26e-05	0.000927	CbGpPWpGaD
Exemestane—CYP19A1—Integrated Breast Cancer Pathway—AKT1—type 2 diabetes mellitus	3.25e-05	0.000923	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	3.22e-05	0.000917	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—GLP1R—type 2 diabetes mellitus	3.18e-05	0.000906	CbGpPWpGaD
Exemestane—CYP3A4—Biological oxidations—GSTM1—type 2 diabetes mellitus	3.01e-05	0.000857	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—SLC2A2—type 2 diabetes mellitus	2.97e-05	0.000846	CbGpPWpGaD
Exemestane—CYP3A4—Metapathway biotransformation—GSTM1—type 2 diabetes mellitus	2.97e-05	0.000845	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—MTR—type 2 diabetes mellitus	2.91e-05	0.000829	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—CPT1A—type 2 diabetes mellitus	2.91e-05	0.000829	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—NAMPT—type 2 diabetes mellitus	2.86e-05	0.000813	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	2.84e-05	0.000808	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—LIPC—type 2 diabetes mellitus	2.84e-05	0.000808	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—HBA1—type 2 diabetes mellitus	2.84e-05	0.000808	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—GCK—type 2 diabetes mellitus	2.84e-05	0.000808	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—CYP11A1—type 2 diabetes mellitus	2.82e-05	0.000803	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—SLC9A1—type 2 diabetes mellitus	2.77e-05	0.000788	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—CETP—type 2 diabetes mellitus	2.74e-05	0.000779	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	2.55e-05	0.000726	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—PSMD6—type 2 diabetes mellitus	2.55e-05	0.000724	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—SNAP25—type 2 diabetes mellitus	2.55e-05	0.000724	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—SREBF1—type 2 diabetes mellitus	2.55e-05	0.000724	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—CTGF—type 2 diabetes mellitus	2.5e-05	0.000711	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—HMGCR—type 2 diabetes mellitus	2.48e-05	0.000705	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	2.44e-05	0.000695	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—ADRA2A—type 2 diabetes mellitus	2.42e-05	0.000689	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—CYP2E1—type 2 diabetes mellitus	2.33e-05	0.000662	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—CYP1A2—type 2 diabetes mellitus	2.3e-05	0.000655	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—SLC2A1—type 2 diabetes mellitus	2.3e-05	0.000655	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—BHMT—type 2 diabetes mellitus	2.3e-05	0.000653	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—CYP3A4—type 2 diabetes mellitus	2.25e-05	0.000639	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	2.23e-05	0.000636	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—SLC2A4—type 2 diabetes mellitus	2.21e-05	0.000628	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—GCG—type 2 diabetes mellitus	2.21e-05	0.000628	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—AANAT—type 2 diabetes mellitus	2.01e-05	0.000571	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—PTGDS—type 2 diabetes mellitus	2.01e-05	0.000571	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—GPD2—type 2 diabetes mellitus	1.9e-05	0.000541	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—CDO1—type 2 diabetes mellitus	1.9e-05	0.000541	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—GNB3—type 2 diabetes mellitus	1.9e-05	0.000541	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.9e-05	0.000541	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—HMOX1—type 2 diabetes mellitus	1.89e-05	0.000539	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—CAT—type 2 diabetes mellitus	1.87e-05	0.000532	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—AK1—type 2 diabetes mellitus	1.82e-05	0.000516	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—APOB—type 2 diabetes mellitus	1.81e-05	0.000516	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—GSTM1—type 2 diabetes mellitus	1.76e-05	0.000502	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—LPL—type 2 diabetes mellitus	1.73e-05	0.000493	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—ADCY5—type 2 diabetes mellitus	1.7e-05	0.000482	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—GPX1—type 2 diabetes mellitus	1.69e-05	0.000481	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—MAT1A—type 2 diabetes mellitus	1.68e-05	0.000477	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—SLC5A4—type 2 diabetes mellitus	1.68e-05	0.000477	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—CD36—type 2 diabetes mellitus	1.65e-05	0.000468	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—PPP2CA—type 2 diabetes mellitus	1.63e-05	0.000462	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—ENPP1—type 2 diabetes mellitus	1.62e-05	0.00046	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—G6PC—type 2 diabetes mellitus	1.62e-05	0.00046	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—PPP1R3C—type 2 diabetes mellitus	1.62e-05	0.00046	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—ND1—type 2 diabetes mellitus	1.62e-05	0.00046	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—HBA2—type 2 diabetes mellitus	1.62e-05	0.00046	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—GCGR—type 2 diabetes mellitus	1.57e-05	0.000446	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—MTHFR—type 2 diabetes mellitus	1.56e-05	0.000444	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—PPARA—type 2 diabetes mellitus	1.53e-05	0.000435	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—AGT—type 2 diabetes mellitus	1.48e-05	0.000422	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—OXCT1—type 2 diabetes mellitus	1.48e-05	0.000421	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—CYTB—type 2 diabetes mellitus	1.48e-05	0.000421	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—CALM1—type 2 diabetes mellitus	1.46e-05	0.000415	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—APOE—type 2 diabetes mellitus	1.45e-05	0.000413	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—SRD5A1—type 2 diabetes mellitus	1.44e-05	0.00041	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—APOA1—type 2 diabetes mellitus	1.44e-05	0.000408	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—ACACA—type 2 diabetes mellitus	1.38e-05	0.000391	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—STAR—type 2 diabetes mellitus	1.38e-05	0.000391	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—HSD17B3—type 2 diabetes mellitus	1.38e-05	0.000391	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—ABCC8—type 2 diabetes mellitus	1.32e-05	0.000375	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—CBS—type 2 diabetes mellitus	1.32e-05	0.000375	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—COX2—type 2 diabetes mellitus	1.27e-05	0.000361	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—SLC5A2—type 2 diabetes mellitus	1.27e-05	0.000361	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—PPARG—type 2 diabetes mellitus	1.26e-05	0.00036	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—NCOA6—type 2 diabetes mellitus	1.25e-05	0.000355	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—INS—type 2 diabetes mellitus	1.24e-05	0.000353	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—HSD11B1—type 2 diabetes mellitus	1.23e-05	0.000349	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—UCP2—type 2 diabetes mellitus	1.23e-05	0.000349	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—UCP3—type 2 diabetes mellitus	1.23e-05	0.000349	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—PCK1—type 2 diabetes mellitus	1.15e-05	0.000328	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—ALB—type 2 diabetes mellitus	1.14e-05	0.000324	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—PIK3R1—type 2 diabetes mellitus	1.09e-05	0.000309	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—NOS3—type 2 diabetes mellitus	1.09e-05	0.000309	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	1.08e-05	0.000307	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	1.04e-05	0.000297	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	1.04e-05	0.000297	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	1.04e-05	0.000297	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	1.04e-05	0.000297	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	1e-05	0.000284	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—PTGS2—type 2 diabetes mellitus	9.95e-06	0.000283	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	9.29e-06	0.000264	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	8.68e-06	0.000247	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	8.5e-06	0.000242	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	8.5e-06	0.000242	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	8.34e-06	0.000237	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	8.28e-06	0.000236	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	8.28e-06	0.000236	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	8.28e-06	0.000236	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	8.23e-06	0.000234	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	8.09e-06	0.00023	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	7.99e-06	0.000227	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	7.43e-06	0.000211	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	7.43e-06	0.000211	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	7.43e-06	0.000211	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	7.29e-06	0.000207	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	7.23e-06	0.000206	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	7.07e-06	0.000201	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	6.8e-06	0.000193	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	6.72e-06	0.000191	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	6.72e-06	0.000191	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	6.44e-06	0.000183	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	6.44e-06	0.000183	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	5.55e-06	0.000158	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	5.55e-06	0.000158	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	5.53e-06	0.000157	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	5.45e-06	0.000155	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	5.29e-06	0.000151	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	5.15e-06	0.000147	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	5.06e-06	0.000144	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—AKT1—type 2 diabetes mellitus	5e-06	0.000142	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	4.95e-06	0.000141	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	4.93e-06	0.00014	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	4.8e-06	0.000137	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	4.74e-06	0.000135	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	4.55e-06	0.000129	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	4.47e-06	0.000127	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	4.32e-06	0.000123	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	4.25e-06	0.000121	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	4.24e-06	0.000121	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	4.19e-06	0.000119	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	3.69e-06	0.000105	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	3.62e-06	0.000103	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	3.32e-06	9.44e-05	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	3.17e-06	9.03e-05	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	3.17e-06	9.03e-05	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	2.9e-06	8.26e-05	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	1.46e-06	4.15e-05	CbGpPWpGaD
